How Much Did Vitable Raise?
Funding & Key Investors

Vitable, a Philadelphia-based innovator in the health benefits sector, has successfully secured a major strategic investment to accelerate its mission of democratizing access to quality medical care. This latest capital injection, totaling $16M, underscores the market's growing appetite for flexible, ACA-compliant alternatives to traditional group insurance. With a cumulative capital raise of $17.6M, the company is well-positioned to scale its operations and further refine its unique model of Direct Primary Care (DPC) for the modern workforce.

The funding trajectory reflects a clear growth path, beginning with early-stage support and culminating in this significant Series A round. By prioritizing accessibility for underinsured and uninsured workers, Vitable has carved out a distinct niche in the competitive health tech landscape, attracting high-profile institutional backing.

What is Vitable?

Vitable
SoftwareHealthcare Software

Vitable Health operates as a comprehensive health benefits platform designed to bridge the gap between employers and employees who are often underserved by conventional insurance models. By integrating unlimited virtual primary care, mental health services, and preventive support, the company effectively reduces administrative complexity while lowering overall healthcare costs. The platform is specifically engineered to support businesses that require scalable, affordable, and people-focused benefits, moving away from the rigid structures of legacy insurance providers. Through its focus on real-world access and transparent pricing, Vitable is redefining how organizations approach employee wellness in an increasingly fragmented healthcare market.

How much funding has Vitable raised?

Vitable has raised a total of $17.6M across 2 funding rounds:

2020

Unspecified

$1.6M

2024

Series A

$16M

Unspecified (2020): $1.6M with participation from Softbank's Opportunity Fund

Series A (2024): $16M led by Newark Venture Partners, Y Combinator, First Round Capital, and Commerce Ventures

Key Investors in Vitable

Newark Venture Partners

NVP Capital is a leading venture capital firm that specializes in providing early-stage funding and strategic support to innovative startups, particularly in the healthcare and technology sectors.

Y Combinator

Established in 2005, Y Combinator is a premier startup accelerator that provides seed funding and mentorship to high-growth companies across various industries.

First Round Capital

First Round is an early-stage venture capital firm known for helping founders build foundational company structures and providing access to a vibrant community of experts.

What's next for Vitable?

With the infusion of this latest capital, Vitable is poised to enter a new phase of enterprise-level expansion. The strategic focus will likely center on enhancing its digital infrastructure to support a larger user base while deepening its integration with existing HR and payroll systems. As the company scales, it will likely leverage its recent financing to broaden its service offerings and strengthen its market presence, aiming to become the primary benefits partner for mid-to-large scale enterprises seeking to optimize their healthcare spend without compromising on the quality of care provided to their staff.

See full Vitable company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Insurance
InsuranceBusiness ServicesProject Management
Insurance
Insurance

Frequently Asked Questions Regarding Vitable Financial Insights

What are the most recent funding rounds that Vitable has completed, and what were the funding rounds?
Vitable has recently completed 2 funding rounds: Series A on Jul 22, 2024, Unspecified on Oct 21, 2020.
What is the total amount of funding Vitable has raised to date?
Vitable has raised a total of $17.6M in funding to date.
How many funding rounds has Vitable completed?
Vitable has completed 2 funding rounds.
How much funding did Vitable raise in its most recent funding round?
Vitable raised $16M in its most recent funding round.
Who are the lead investors in Vitable's latest funding round?
The lead investor in Vitable's latest funding round was Newark Venture Partners. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Vitable's history?
The largest funding round in Vitable's history was $16M.
See more information about Vitable